Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

COVID-19 Positive STEMI Patients Have Higher Mortality, First data presented at #TCT2020 on COVID heart attack patients.

Getty Images

News | Coronavirus (COVID-19) | October 14, 2020
COVID-19 Positive STEMI Patients Have Higher Mortality 
October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction...
read more
Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.

Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.

Feature | October 09, 2020 | Udi Nussinovitch M.D., Ph.D.
What is New in Cardiology? A Review of All Major Emerging Technologies for Heart Diseases
This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail...
read more
Videos | Radial Access | October 07, 2020
VIDEO: Radial Access Recovery Lounges Aid Patient Satisfaction and Comfort Post-PCI
Jordan G. Safirstein, M.D., FACC, FSCAI, director of transradial catheterization for Atlantic Health System’s...
read more
The Latest Vascular Interventional Clinical Data Presented at VIVA 2020 late-breaking sessions
News | VIVA | October 05, 2020
The Latest Vascular Interventional Clinical Data Presented at VIVA 2020
October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical...
read more
The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.
News | Heart Valve Technology | October 02, 2020
Cardiac Dimensions Announces $17.5 Million in Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System
October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be...
read more
Videos | Left Atrial Appendage (LAA) Occluders | October 02, 2020
VIDEO: Overview of Left Atrial Appendage (LAA) Closure Technology and New Innovations
Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal...
read more
The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario, Canada, represents a new frontier in cardiac surgery. The customized OR features a Siemens Artis Pheno angiogray system with  3-D imaging capability with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.

The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario, Canada, represents a new frontier in cardiac surgery. The customized OR features a Siemens Artis Pheno angiogray system with  3-D imaging capability with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.

News | Hybrid OR | October 02, 2020
Intelligent Hybrid Operating Room Help Redefine Cardiac Care at London Health Sciences Centre
October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario...
read more
The FDA has cleared a new indication for the Medtronic Resolute Onyx Drug Eluting Stent, making it the first DES that only required one month of dual antiplatelet therapy (DAPT) in patients who are considered high risk for bleeding complications.

The FDA has cleared a new indication for the Medtronic Resolute Onyx Drug Eluting Stent, making it the first DES that only required one month of dual antiplatelet therapy (DAPT) in patients who are considered high risk for bleeding complications.

News | Stents | October 01, 2020
Medtronic Resolute Onyx Drug Eluting Stent First to Receive One-Month DAPT Indication
October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-...
read more
The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.

The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.

News | Optical Coherence Tomography (OCT) | October 01, 2020
World’s Smallest Intravascular OCT Imaging Device Created Using 3-D Printing
October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D...
read more
The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.

The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.

Feature | October 01, 2020 | Dave Fornell, Editor
Most Popular Cardiology Technology Content in September 2020
October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
read more
Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI
News | Heart Valve Technology | September 29, 2020
Boston Scientific Launches Acurate neo2 Transcatheter Aortic Valve System in Europe
September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system...
read more
Philips introduced the QuickClear Mechanical Thrombectomy System. It is a simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system.

Philips introduced the QuickClear Mechanical Thrombectomy System. It is a simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system.

News | Thrombectomy Devices | September 25, 2020
Philips Introduces QuickClear Mechanical Thrombectomy System for Blood Clot Removal
September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use...
read more
The Optimizer Smart System is a pacemaker-like device that improves heart function and reduces debilitating symptoms associated with the disease, including fatigue and shortness of breath.
News | Heart Failure | September 23, 2020
Allegheny General Hospital Cardiologists First in the Region to Use Novel Implantable Device to Treat Heart Failure
September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN...
read more
Videos | Artificial Intelligence | September 21, 2020
VIDEO: Artificial Intelligence May Improve Cath Lab Interventions
Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and...
read more
TCT 2020 Late-breaking Study trial Presentations Announced
Feature | TCT | October 15, 2020
TCT 2020 Late-breaking Study Presentations Announced
October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular...
read more
© Copyright Wainscot Media. All Rights Reserved.